Sino Biopharmaceutical Limited (HKG:1177)
Hong Kong · Delayed Price · Currency is HKD 5.54
-0.02 (-0.36%)
Nov 11, 2026, 4:08 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 98.58 billion as of November 10, 2026. It is the 1,813th most valuable company in the world and the 93rd biggest in Hong Kong. Its market cap has decreased by 20.77% in one year.
Market Cap
98.58B
Enterprise Value
102.35B
Revenue
38.91B
Global Rank
Country Rank
#93 Hong Kong
PE Ratio
36.11
ChartMarket Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 98.58B, an increase of 29,774.57%. That is a compound annual growth rate of 24.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 98.58B | -10.77% |
| Dec 31, 2025 | 110.48B | 89.64% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 364.46B |
| WuXi Biologics | 200.75B |
| Innovent Biologics | 150.50B |
| Sichuan Kelun-Biotech Biopharmaceutical | 111.15B |
| Akeso | 83.48B |
| Genscript Biotech | 71.43B |
| RemeGen | 55.33B |
| 3SBio | 37.78B |